test

Current Funding Opportunities

Department of Defense Breast Cancer Research Program
Era of Hope Scholar Award
Independent, non-mentored investigators within 6 years of their last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of the application submission deadline

  • Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields.
  • PIs should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. 
  • PIs should exhibit strong potential for leadership in the breast cancer community 
  • PIs must include breast cancer advocates on their research team. 
  • Maximum funding of $2.5M for direct costs (plus indirect costs) 
  • Period of performance not to exceed 5 years 

Letter of Intent Deadline: August 1, 2014
Application Deadline: August 15, 2014 

Innovator Award
Associate Professor or above (or equivalent)

  • Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field
  • Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer
  • PIs must include breast cancer advocates on their research team
  • Nomination is required; self-nominations are accepted; application submission is by invitation only
  • Maximum funding of $5M for direct costs (plus indirect costs) 
  • Period of performance not to exceed 5 years 

Nomination Deadline: May 14, 2014
Invited Application Deadline: August 15, 2014

Breakthrough Award 

  • Investigators at all academic levels (or equivalent) 
  • Postdoctoral fellows are eligible to apply 
  • Supports promising research that has the potential to lead to or make breakthroughs in breast cance
  • Potential impact of the research may be near-term or long-term, but it must be significant and go beyond an incremental advancement
  • Partnering PI Option allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application
  • Four different funding levels, based on the scope of research, are available. It is the responsibility of the PI to select the funding level that is most appropriate for the research proposed
  • Period of performance not to exceed 5 years

Letter of Intent Deadline: May 14, 2014
Full Application Deadline: May 28, 2014

Learn More>>

V Foundation Translational Research Grant in Bladder Cancer
A maximum of one Letter of Intent (LOI) per institution will be accepted for this funding opportunity, which will fund a project over two years for $300,000-400,000.  The LOI should outline your specific proposed translational project in bladder cancer. The letter should: 
* Be no more than two pages in length;
* Provide proposed project title and short summary, explain the translational nature of the research, and discuss its potential impact on people with or at risk of bladder cancer.
If you are interested in submitting a LOI to the V Foundation, please contact Dan DiMaio for consideration.  The LOI from Yale Cancer Center is due to the V Foundation on April 30th.

Lung Cancer Research Foundation Grants
Support research on innovate strategies for better treatments, screening, and prevention of all cancers of the lung. These awards are designed to provide critical seed support for cutting-edge scientific research on all lung cancers and will support projects with a focus on basic science, translational research, clinical research, supportive care, and quality of care/outcomes. Up to $50,000 for 1 year.
Application Deadline: June 16, 2014

Learn More>>

Alex's Lemonade Stand Foundation
We are pleased to announce that grant guidelines and applications are now open for submission in the following categories:

Bridge Grants Cycle
This grant is designed to sustain research projects falling between the end of funding by the National Institutes of Health (NIH) R or P Award and the beginning of a competitively renewed NIH Award. Renewal applications which scored less than or equal to the 35th percentile but were not funded will be eligible for Bridge Grants. Applicants must have a plan to resubmit for NIH funding. This is a one year award of $100,000 in total costs.
Application Deadline: April 10, 2014

Springboard Grants Cycle
This grant supports new National Institutes of Health (NIH) R01 or P01 research applications which were scored less than or equal to the 25th percentile but were not funded. Applicants must have a plan to resubmit for NIH funding. This is a one year award of $100,000 in total costs.
Application Deadline: April 10, 2014

'A' Awards
NEW in 2014, the award amount has increased to $150,000 per year for three years! Designed for early career scientists with an original project who can demonstrate outstanding mentorship and have a strong future commitment to pediatric cancer investigation. This award totals $450,000 over three years and is open to MD, MD/PhD and PhD candidates.  
Application Deadline: May 23, 2014

Reach Awards
Our Reach Awards are designed to move hypothesis-driven research toward the clinic. The goal of this award is to support selected "late translational" studies needed to ultimately initiate a clinical trial. A successful application will identify an unmet clinical need relevant to the care of pediatric cancer patients and describe how the proposed project will allow for the pre-clinical research to be translated to the clinic while keeping broader clinical testing and implementation in view. Maximum of $250,000 in total costs awarded over two years.
Application Deadline: May 30, 2014

Learn More>>